Search Ontology:
ChEBI

beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-alpha-L-Fucp

Term ID
CHEBI:146984
Synonyms
  • beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-6-deoxy-alpha-L-galacto-hexopyranose
  • beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-6-deoxy-alpha-L-galactopyranose
  • Gal(b1-3)GlcNAc(b1-4)a-Fuc
  • N-[(2S,3R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2S,3S,4S,5S,6R)-4,5,6-trihydroxy-2-methyloxan-3-yl]oxyoxan-3-yl]acetamide
Definition
An aminotrisaccharide consisting of β-D-galactopyranosyl, 2-acetamido-β-D-glucopyranosyl and α-L-fucopyranosyl residues joined in sequence by (1→3) and (1→4) glycosidic bonds.
References
  • glygen:G06414UP
  • glytoucan:G06414UP
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-alpha-L-Fucp
Phenotype where environments contain beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-alpha-L-Fucp
Phenotype modified by environments containing beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-alpha-L-Fucp
Phenotype affecting beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-alpha-L-Fucp
Human Disease Model